Decellularized Matrix from Tumorigenic Human Mesenchymal Stem Cells Promotes Neovascularization
Author Information
Author(s): Jorge S. Burns, Malthe Kristiansen, Lars P. Kristensen, Kenneth H. Larsen, Maria O. Nielsen, Helle Christiansen, Jan Nehlin, Jens S. Andersen, Moustapha Kassem
Primary Institution: University of Southern Denmark
Hypothesis
How do mesenchymal stem cells promote neovascularization?
Conclusion
The decellularized matrix from tumorigenic hMSC has significant angiogenic potential, requiring galectin-1 for optimal endothelial interactions.
Supporting Evidence
- Clone -BD11 produced a denser extracellular matrix that supported stable ex vivo capillary morphogenesis.
- Decellularized -BD11 matrix promoted human endothelial cell tubular morphogenesis ex vivo.
- siRNA knock down of galectin-1 expression abrogated the ex vivo interaction between decellularized -BD11 matrix and endothelial cells.
Takeaway
This study shows that a special type of cell from tumors can help form new blood vessels, which is important for cancer growth.
Methodology
The study used quantitative qRT-PCR, proteomic characterization, and in vivo assays to analyze the effects of decellularized matrices on endothelial cells.
Potential Biases
Potential biases related to the specific cell lines used and their tumorigenic characteristics.
Limitations
The study may introduce biases specific to the angiogenic potency of telomerized hMSC within the context of tumor formation.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website